AAAAAA
Results:
1-12
|
Results: 12
Authors:
Levenback, C
Coleman, RL
Burke, TW
Bodurka-Bevers, D
Wolf, JK
Gershenson, DM
Citation: C. Levenback et al., Intraoperative lymphatic mapping and sentinel node identification with blue dye in patients with vulvar cancer, GYNECOL ONC, 83(2), 2001, pp. 276-281
Authors:
Ramirez, PT
Ramondetta, LM
Burke, TW
Gershenson, DM
Brewer, MA
Citation: Pt. Ramirez et al., Metastatic uterine papillary serous carcinoma to the pericardium, GYNECOL ONC, 83(1), 2001, pp. 135-137
Authors:
Donato, ML
Gershenson, DM
Wharton, JT
Ippoliti, CM
Aleman, AS
Bodurka-Bevers, D
Bevers, MW
Burke, TW
Levenback, CF
Wolf, JK
Freedman, RS
Bast, RC
Gajewski, JL
Champlin, RE
Citation: Ml. Donato et al., High-dose topotecan, melphalan, and cyclophosphamide (TMC) with stem cell support: A new regimen for the treatment of advanced ovarian cancer, GYNECOL ONC, 82(3), 2001, pp. 420-426
Authors:
Ramirez, PT
Levenback, C
Burke, TW
Eifel, P
Wolf, JK
Gershenson, DM
Citation: Pt. Ramirez et al., Sigmoid perforation following radiation therapy in patients with cervical cancer, GYNECOL ONC, 82(1), 2001, pp. 150-155
Authors:
Ramondetta, L
Burke, TW
Levenback, C
Bevers, M
Bodurka-Bevers, D
Gershenson, DM
Citation: L. Ramondetta et al., Treatment of uterine papillary serous carcinoma with paclitaxel, GYNECOL ONC, 82(1), 2001, pp. 156-161
Authors:
Burke, TW
Cook, JG
Asano, M
Nevins, JR
Citation: Tw. Burke et al., Replication factors MCM2 and ORC1 interact with the histone acetyltransferase HBO1, J BIOL CHEM, 276(18), 2001, pp. 15397-15408
Authors:
Ramondetta, L
Mills, GB
Burke, TW
Wolf, JK
Citation: L. Ramondetta et al., Adenovirus-mediated expression of p53 or p21 in a papillary serous endometrial carcinoma cell line (SPEC-2) results in both growth inhibition and apoptotic cell death: Potential application of gene therapy to endometrial cancer, CLIN CANC R, 6(1), 2000, pp. 278-284
Authors:
Pustilnik, T
Burke, TW
Citation: T. Pustilnik et Tw. Burke, Adjuvant chemotherapy for high-risk endometrial cancer, SEM RAD ONC, 10(1), 2000, pp. 23-28
Authors:
Wolf, JK
Mullen, J
Eifel, PJ
Burke, TW
Levenback, C
Gershenson, DM
Citation: Jk. Wolf et al., Radiation treatment of advanced or recurrent granulosa cell tumor of the ovary, GYNECOL ONC, 73(1), 1999, pp. 35-41
Authors:
Gershenson, DM
Morris, M
Burke, TW
Levenback, C
Wolf, J
Lee, JJ
Thall, PF
Atkinson, EN
Silva, EG
Wharton, JT
Citation: Dm. Gershenson et al., A Phase I trial of intravenous melphalan, paclitaxel, and cisplatin plus granulocyte-colony stimulating factor in patients with suboptimal advanced epithelial ovarian carcinoma or peritoneal carcinoma, CANCER, 86(11), 1999, pp. 2291-2300
Authors:
Lin, PS
Gershenson, DM
Bevers, MW
Lucas, KR
Burke, TW
Silva, EG
Citation: Ps. Lin et al., The current status of surgical staging of ovarian serous borderline tumors, CANCER, 85(4), 1999, pp. 905-911
Authors:
Burke, TW
Willy, PJ
Kutach, AK
Butler, JEF
Kadonaga, JT
Citation: Tw. Burke et al., The DPE, a conserved downstream core promoter element that is functionallyanalogous to the TATA box, COLD S HARB, 63, 1998, pp. 75-82
Risultati:
1-12
|